Danaher Co. (NYSE:DHR) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 4,720,000 shares, a decrease of 17.5% from the March 15th total of 5,720,000 shares. Based on an average daily volume of 2,590,000 shares, the short-interest ratio is presently 1.8 days. Currently, 0.8% of the shares of the stock are sold short.
NYSE:DHR opened at $241.85 on Wednesday. The company has a market cap of $172.46 billion, a P/E ratio of 48.96, a price-to-earnings-growth ratio of 1.92 and a beta of 0.72. Danaher has a twelve month low of $151.37 and a twelve month high of $248.86. The business has a 50 day moving average price of $224.83 and a two-hundred day moving average price of $228.60. The company has a quick ratio of 1.68, a current ratio of 2.08 and a debt-to-equity ratio of 0.63.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, January 28th. The conglomerate reported $2.08 EPS for the quarter, beating the consensus estimate of $1.84 by $0.24. The firm had revenue of $6.76 billion during the quarter, compared to analysts' expectations of $6.62 billion. Danaher had a return on equity of 12.94% and a net margin of 18.05%. The business's quarterly revenue was up 38.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.28 earnings per share. As a group, analysts anticipate that Danaher will post 6.05 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 30th. Investors of record on Friday, March 26th will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.35%. This is an increase from Danaher's previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Thursday, March 25th. Danaher's payout ratio is presently 19.00%.
In other Danaher news, SVP Angela S. Lalor sold 6,437 shares of Danaher stock in a transaction that occurred on Friday, February 12th. The stock was sold at an average price of $244.70, for a total transaction of $1,575,133.90. Following the sale, the senior vice president now directly owns 25,148 shares of the company's stock, valued at $6,153,715.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.70% of the company's stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Brasada Capital Management LP lifted its holdings in Danaher by 40.9% during the 3rd quarter. Brasada Capital Management LP now owns 49,539 shares of the conglomerate's stock worth $10,667,000 after purchasing an additional 14,384 shares during the last quarter. Great West Life Assurance Co. Can lifted its holdings in shares of Danaher by 1.0% during the third quarter. Great West Life Assurance Co. Can now owns 554,877 shares of the conglomerate's stock worth $119,454,000 after buying an additional 5,582 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in shares of Danaher in the third quarter valued at about $846,000. IHT Wealth Management LLC grew its stake in shares of Danaher by 2.2% in the third quarter. IHT Wealth Management LLC now owns 2,212 shares of the conglomerate's stock valued at $476,000 after acquiring an additional 48 shares in the last quarter. Finally, Kingsview Wealth Management LLC increased its position in Danaher by 60.8% during the third quarter. Kingsview Wealth Management LLC now owns 27,145 shares of the conglomerate's stock worth $5,845,000 after acquiring an additional 10,259 shares during the period. Institutional investors and hedge funds own 78.00% of the company's stock.
A number of brokerages recently issued reports on DHR. Credit Suisse Group increased their target price on shares of Danaher from $260.00 to $264.00 and gave the stock an "outperform" rating in a research report on Thursday, January 14th. Zacks Investment Research lowered shares of Danaher from a "hold" rating to a "sell" rating and set a $241.00 price target for the company. in a report on Friday, April 9th. Finally, Barclays assumed coverage on Danaher in a research note on Monday, March 8th. They set an "overweight" rating and a $260.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and twelve have issued a buy rating to the company's stock. The company has an average rating of "Buy" and a consensus target price of $237.33.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Total Return
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: What is a management fee?7 Lithium Stocks That Will Power the Electric Vehicle Boom
Demand for lithium is set to increase exponentially in the next few years. In fact, according to Statista, demand for lithium may very well double to 820,000 tons in that time. Some of that demand will come from companies that are manufacturing the batteries that we use every day. For example, lithium is an essential component of the batteries that power our mobile devices.
But the real growth will come as the United States goes all-in on electric vehicles (EVs). The Biden administration recently announced plans to have the U.S. government’s fleet of over 600,000 vehicles converted to EVs.
And as you’re aware, EV stocks are in a bubble of some sort at the moment. Some of that is due to the increasing number of companies that went public last year. However, as investors are beginning to realize, not all of these companies will be the next Tesla. In fact, some of these companies may never be successful at bringing an EV to market, at least not at the scale that will be required.
The ones that do make it will need lithium and lots of it. To help you sift through the best lithium stocks to buy, we’ve put together this special presentation.
View the "7 Lithium Stocks That Will Power the Electric Vehicle Boom"